Company | Imperial Brands CEO: Expects double-digit NGP growth over the next five years; ZONE nicotine pouches reach ~3% share in the U.S.

Sep.12.2025
Company | Imperial Brands CEO: Expects double-digit NGP growth over the next five years; ZONE nicotine pouches reach ~3% share in the U.S.
At the Barclays Global Consumer Staples Conference, the CEO of Imperial Brands outlined the company’s 2025–2030 strategy and direction for its Next-Generation Products (NGP). He said the NGP business has been “reset,” delivering double-digit growth over the past two years, with the aim of sustaining this pace for the next five years. In response to disposable-vape bans in the UK and France, the company has completed a pivot to rechargeable pod systems, doubling its UK market share and surpassing

Key Points

 

  • Growth target: Imperial aims to sustain double-digit net revenue growth in Next-Generation Products (NGP) for the next five years; the company says it has delivered double-digit growth over the past two years with share gains across its three NGP categories.

 

  • Go-to-market: Primarily organic growth, supplemented by small bolt-on M&A; entry focus on markets where the category is established and route-to-market is in place.

 

  • UK/France shift: Following disposable vape bans, the business has pivoted to rechargeable pod systems; UK vapor share has doubled in the past 12 months and exceeded 10% in H1.

 

  • U.S. oral nicotine: ZONE, launched in Feb 2024, has reached about 3% market share in ~18 months; a more moist pouch option has been introduced, with emphasis on regulatory compliance.

 

  • Portfolio mix: NGP revenue is roughly 75% vapor / 25% oral nicotine; CEO Stefan Bomhard says new launches will be prioritized only once categories reach sufficient scale (e.g., delaying pouches in the UK until the market matures).

 


 

2Firsts, September 12, 2025 — In a fireside chat at the Barclays Global Consumer Staples Conference, Imperial Brands CEO Stefan Bomhard outlined the company’s 2025–2030 strategy and direction for Next-Generation Products (NGP). He said Imperial has “reset” its NGP business over the past five years, delivering double-digit growth in the last two and gaining share across its three NGP categories. The group is targeting another five years of double-digit NGP growth.

 

On market selection and expansion, Bomhard said Imperial prioritizes countries where the category is already established and distribution is in place, launching differentiated propositions against clear consumer needs. He reiterated Imperial’s positioning as the world’s fourth-largest tobacco company.

 

Addressing policy shifts in Europe, he noted that after the disposable-vape bans in the UK and France, Imperial transitioned its offers to rechargeable pod systems. Over the past 12 months, the company’s UK vapor share has doubled, and in the first half it surpassed 10% for the first time. Pods will remain the core of its UK and French supply strategy.

 

In the United States, the ZONE nicotine-pouch brand, launched in February 2024, has reached around 3% market share in roughly 18 months. Imperial has added a more moist pouch option and stressed adherence to regulatory processes. As for introducing pouches in the UK, Bomhard described the category as “small and fragmented,” indicating Imperial will wait for the market to stabilize before entering.

 

Imperial’s NGP mix is about 75% vapor and 25% oral nicotine. The company will expand in a disciplined manner—largely organically—with small acquisitions considered only as supplements, keeping a tight focus on consumer insight and execution in the trade.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
The U.S. Food and Drug Administration (FDA) announced on May 5, 2026 that it authorized the marketing of four Glas electronic nicotine delivery system (ENDS) products through the premarket tobacco product application (PMTA) pathway. The authorized products are Classic Menthol, Fresh Menthol, Gold and Sapphire pods, each containing 50mg/ml, or 5%, tobacco-derived nicotine.
May.06 by 2FIRSTS.ai
Philippine Health Department Pushes Total Vape Ban, With Tobacco-Only Flavor Limit as Alternative
Philippine Health Department Pushes Total Vape Ban, With Tobacco-Only Flavor Limit as Alternative
The Philippine Department of Health said it is pushing for a total ban on vape products. If a full ban is not feasible, DOH officer-in-charge Director Dr. Dominic Maddumba said vape products should at least be limited to plain tobacco flavors to reduce their appeal to minors.
May.06 by 2FIRSTS.ai
Altria and Juul Ask Court to Pause Antitrust Case Pending Ninth Circuit Review
Altria and Juul Ask Court to Pause Antitrust Case Pending Ninth Circuit Review
Altria and Juul are asking a California federal court to pause an antitrust case while they appeal a class certification ruling to the Ninth Circuit. The case alleges that Altria’s 2018 investment in Juul, a $12.8 billion deal for a 35% stake.
May.07 by 2FIRSTS.ai
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Center for Tobacco Products Acting Director Bret Koplow issued a statement on May 7 outlining new steps to accelerate tobacco product premarket application review. The statement said CTP reduced the backlog of applications by approximately 70% in 2025 and that there is no longer a queue for PMTAs pending acceptance review.
May.09 by 2FIRSTS.ai
Philip Morris Limited Launches Delia to Expand IQOS Iluma Consumables Portfolio
Philip Morris Limited Launches Delia to Expand IQOS Iluma Consumables Portfolio
Philip Morris Limited has announced the launch of Delia, the latest addition to its portfolio of heated tobacco and zero-tobacco sticks exclusively compatible with the IQOS Iluma range.
Apr.03 by 2FIRSTS.ai
Guernsey Rejects Petition to Overturn Under-18 Vape Shop Ban
Guernsey Rejects Petition to Overturn Under-18 Vape Shop Ban
A petition seeking to overturn a new ban on under-18s entering vape shops in Guernsey has been rejected. The Health and Social Care Committee said the measure meets its objective of protecting children from exposure to vaping products.
Mar.23 by 2FIRSTS.ai